| Product NDC: | 0781-3085 |
| Proprietary Name: | Aristospan |
| Non Proprietary Name: | Triamcinolone Hexacetonide |
| Active Ingredient(s): | 20 mg/mL & nbsp; Triamcinolone Hexacetonide |
| Administration Route(s): | INTRA-ARTICULAR; PARENTERAL |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-3085 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA016466 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19690729 |
| Package NDC: | 0781-3085-71 |
| Package Description: | 1 VIAL in 1 CARTON (0781-3085-71) > 1 mL in 1 VIAL |
| NDC Code | 0781-3085-71 |
| Proprietary Name | Aristospan |
| Package Description | 1 VIAL in 1 CARTON (0781-3085-71) > 1 mL in 1 VIAL |
| Product NDC | 0781-3085 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Triamcinolone Hexacetonide |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRA-ARTICULAR; PARENTERAL |
| Start Marketing Date | 19690729 |
| Marketing Category Name | NDA |
| Labeler Name | Sandoz Inc |
| Substance Name | TRIAMCINOLONE HEXACETONIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |